Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Put in a STOP ORDER. It will protect you from the down side.
Congrats, I'm with you guys. After hanging in there for three years it nice to see IMGG take off to the moon.
Thank You.
I am under the impression that if a shareholder receives stock in a purchaseing company that they do not have to pay taxes on the stock until it is sold. If they recieve cash then taxes are due on the gain. Does anyone know if this is correct.
Dean told about the most recent docs that I3 is giving FDA in the most recent conference call. If you have not had a chance to listen to it you can get a link to it at the I3 website.
http://www.imaging3.com/
Click on the link to it in the lower left hand corner.
Thanks for the link.
Thanks for the chart. Here's something everyone may be interested in that I found on the HDVY board that mentions IMGG.
The Dominion would reduce costs of care and be more accessable to medical care providers. A CT scanner costs around $2 million. The Dominion with CT capability around $ 500,000. That would reduce costs associated with needed scans. Wouldn't that be helpful in an invironment where costs are trying to be reduced?
An example, Two members of my family had work related injuries in the last year. In both cases CT scans were not being authorized by their insurance companies because of the cost of the scan. They were both sent to Physical Therapy which did not help. Then they were allowed to have the scans which found their problems and corrective action taken.
I think a 75% savings on the cost of a scan would bring a lot of reduced cost to companies and save a lot of pain to patients.
I just can not see the administration "taking a whack" at products that could save lives and money.
In the past hostile takeovers occurred when a large investor would accumulate large blocks of stock, which is part ownership of a company. They would offer to buy stock at high prices in an effort to get a controlling vote. Once that was done management was replaced and assets were sold to pay for the stock that was purchased. Now, most companies protect themselves by getting authorization to sell a very large amount of stock. If someone tries to takeover they then have control of enough stock to retain a controling interest.
Companies prefer to trade on either NASDAQ or NYSE. The NASDAQ has many requirements like a minimum share price. I think that it is $1.00. If they fall below that they are delisted. It is more a matter of meeting requirements than share price.
Thanks for your comments. This shows how the low dose that the Dominion puts out will help those of you in the medical profession.
Thanks Dean for your response. I bought shares almost three years ago and being open and straight forward with investors is what has kept me here. And, it does take capital to manufacture a fine product. The way you raised capital is very understandable to me. This way you retain ful control over your company and the investor gets paid when the company sees success.
Thanks Again
I could not get on the conference call either. I sent an email to I3 and asked when it would be available to listen to. Here's the reply:
I apologize for any inconvenience. We are experiencing technical difficulties, due to extraordinarily high call volume. The conference call will be available on the company’s website, www.imaging3.com, following the call. Again, I apologize for any inconvenience.
Thank you
Becky
Wow!!! What a wild day this has been. It looks like .381 at the close. Now, what's going to happen tomarrow?
Thanks for the link. It is a very detailed report.
Did anyone pickup on the news story about IMGG raising more capital. Its not in the normal places that I look for news. This is where I found it.
http://ih.advfn.com/p.php?pid=squote&symbol=IMGG
We're on a roll today. In the last few minutes all of the .17 asks were taken and there are just a few in .18. A lot of .20 asks. Info at:
http://otcbb.com/asp/Info_Center.asp
8,000,000 Shares!!!!! WOW!!!!
Yeah! It looks like IMGG is raising operating capital again.
I'v been an investor for almost three years and everything that Dean has said in conference calls and news releases leads me to beleive that he wants to build a strong company. Although, he has said that he would not rule out a buyout if the offer was significant.
When we get FDA approval we should get a good increase in Price Per Share like what is going on with ENCO today. ENCO got a contract for Swine Flu Vaccine. its PPS went from .21, yesterdays close, to opening at $1.23 and then dropped to .80 in first hour of trading. This could happen to us. I do not own any ENCO just thought is was of interest to us.
Nice volume today. It looks like good support at .09.
Does anyone know if IMGG finished their computer upgrades and submitted it to FDA? Dean said that they thought it would be done by Sept. 1.
The Dominion is like my home improvement projects. It always takes longer than expected but eventualy gets done.
Hi Tryn
It looks like the profit takers are in the market today. We are all waiting for some news. I'm still sitting on the side lines on HDVY. It needs some news too.
Go get that 5 pounder this weekend. I'll call you.
Sonoma West
Thats a great start. It beats the heck out of .03. This stock was begining to remind of a telecom stock I had in 2001.
This probably does not affect IMGG but I thought I would pass this news story on to those of you who are interested:
WASHINGTON (AP) -- The head of the Food and Drug Administration's medical device division announced Tuesday he will step down, months after scientists under his leadership alleged they were pressured to approve certain products.
In a letter to agency staffers obtained by The Associated Press, Daniel Schultz said he and FDA Commissioner Margaret Hamburg agreed his resignation "would be in the best interest of the center and the agency."
FDA's device division, which Schultz led for five years, has been under scrutiny since earlier this year when nine scientists wrote to the Obama administration transition team complaining they were pressured to approve medical devices against their professional judgment.
Since then, lawmakers including Rep. Henry Waxman, D-Calif., and Sen. Chuck Grassley, R-Iowa, have sent letters to FDA investigating the matter.
Specifically, between 2006 and 2008, FDA scientists repeatedly rejected a knee repair device from Regen Biologics, a company based in Hackensack, N.J. In a 2007 rejection letter to the company, an FDA reviewer said the company's device had "an increased risk" compared with products already on the market. FDA scientists recommended rejecting another application from the company in fall 2008, saying Regen had not shown "that patients who received the device experienced any benefit."
Despite these concerns, Schultz approved the device in late 2008.
Consumer health advocates hailed the news of Schultz's departure as evidence of a new direction at the FDA.
"This change in leadership will bring hope to many patients who have been very concerned about the safety of medical devices," said Dr. Diana Zuckerman, of the National Research Center for Women and Families in Washington.
The FDA has been plagued for years by criticisms of dysfunction, following the recalls of drugs like Vioxx -- which was linked to heart attack and stroke years after its approval -- and a string of outbreaks of food-borne illnesses like salmonella.
President Obama tapped Hamburg, a former New York City health commissioner, earlier this year to try and restore the agency's credibility. Hamburg said Tuesday that Associate Commissioner Jeff Shuren would serve as interim director for devices until a permanent replacement is found.
Thank You Dean for the update. It is very much appreciated.
Gentlemen, Would you please return to a more business like manner on this board. This would incourage those who have something important to say to return to the board.
Like members of the management of IMGG.
Very good interview today on Money TV.
Everyone needs to watch it.
Is someone trying to manipulate the price per share?
Today someone sold 290 shares at .0475 for $13.775. With the negative talk on this board and another board, does someone wants the price down? The reason why some people avoid small stocks is because its to easy to manipulate them.
"Imminent Approval" was 13 months ago and the share price was .10.
I am concerned about this. Perhaps Sano has a point!!!!!
Thank you for the update Dean. Its always hard when we are in a Hurry-up and Wait stage but I'm sure it will be worth the wait when FDA comes thru.
According to info on this website I crunched some numbers.
150 units per year
x $550,000 sales price per unit
______________________
$82,500,000 sales per year
50% profit
______________________
41,250,000 Gross Profit
250,000,000 shares outstanding
.165 cents per share
At a PE of 10 = $1.65 per share.
At a PE of 20 = $3.30 per share.
This is just a rough estimate. So my guess at the start could be $1.00 bassed on future earnings.
Yes, that would be nice. Since I paid .12 and now the PPS is .046 and other opportunities come and go, now would be a good time for a pep talk.
Mr. Sano: I'll say up to a $1 with full approval.
Kimble. Congrats on holding DNDN
Guys like us are in it for the long haul anyway. When FDA approves we can smile bigtime. Look a Dendreon DNDN it went from $6.00 to over $20 yesterday on good news on its prostate drug. We can do the same or better.
Only $ 0.04 today. What is this!!! I was a little upset with this but checked Level II to find out that some guy sold 500 shares for .04 at the end. Fortunately a $20 trade doesn't set a precedent. Wow, the commission for the trade was probably that much.
Poppo, thanks for the info.
For those of you who are new investors, It is common practice for corporations to develope a way of preventing hostile take overs. The practice was started in the 1980's when large companies were taken over by wealthy individuals and then management and empoyees were fired. Stockholders usually got a better price for their stock but were forced to sell at whatever price the takeover party wanted. In manufacturing the product was then manufactured offshore and all facilities shut down and sold.
This move by IMGG tells me that Dean wants to manufacture the Dominion when FDA approves and not be controlled by an outsider.
I hope that this is the case. I noticed that on Jan. 7 there was a news release ( EDGAR 4) that showed Dean had sold 500,000 shares in the month of December. I assume that from past posts that it was to generate working capital. I can't help but wonder if this is the case here to.
Something Positive!! IMGG was the only stock showing a GREEN arrow (up tick)yesterday on my list of stocks and mutual funds that I monitor daily.
Thanks for the good work Dean. It just shows that RSNA and TV programs are keeping IMGG in a positive light in the eyes of investors.
Thanks Chevyman, sometimes the technical FDA stuff can be a little confusing and I like to make sure that I understand it.